EQNCX
Price
$23.46
Change
+$0.14 (+0.60%)
Updated
Oct 17 closing price
Net Assets
674.51M
RWEBX
Price
$66.32
Change
+$0.27 (+0.41%)
Updated
Oct 17 closing price
Net Assets
206.71B
Interact to see
Advertisement

EQNCX vs RWEBX

Header iconEQNCX vs RWEBX Comparison
Open Charts EQNCX vs RWEBXBanner chart's image
MFS Equity Income C
Price$23.46
Change+$0.14 (+0.60%)
VolumeN/A
Net Assets674.51M
American Funds Washington Mutual R2E
Price$66.32
Change+$0.27 (+0.41%)
VolumeN/A
Net Assets206.71B
EQNCX vs RWEBX Comparison Chart in %
View a ticker or compare two or three
VS
EQNCX vs. RWEBX commentary
Oct 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EQNCX is a Buy and RWEBX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWEBX has more cash in the bank: 207B vs. EQNCX (675M). EQNCX pays higher dividends than RWEBX: EQNCX (1.19) vs RWEBX (0.76). EQNCX was incepted earlier than RWEBX: EQNCX (13 years) vs RWEBX (11 years). EQNCX (1.70) is less costly to investors than RWEBX (1.06). EQNCX is a more actively managed with annual turnover of: 40.00 vs. RWEBX (29.00). RWEBX has a lower initial minimum investment than EQNCX: RWEBX (250) vs EQNCX (1000). EQNCX annual gain was more profitable for investors over the last year : 4.60 vs. RWEBX (3.29). EQNCX return over 5 years is better than : 53.08 vs. RWEBX (45.88).
EQNCXRWEBXEQNCX / RWEBX
Total Expense Ratio1.641.06155%
Annual Report Gross Expense Ratio1.701.06160%
Fund Existence13 years11 years-
Gain YTD12.6469.079139%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets675M207B0%
Annual Yield % from dividends1.190.76157%
Returns for 1 year4.603.29140%
Returns for 3 years39.4938.78102%
Returns for 5 years53.0845.88116%
Returns for 10 years96.7973.45132%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GRF11.110.36
+3.35%
Eagle Capital Growth Fund
PBE72.230.49
+0.68%
Invesco Biotechnology & Genome ETF
APIE36.000.20
+0.56%
ActivePassive International Equity ETF
IVV667.693.71
+0.56%
iShares Core S&P 500 ETF
IBGA25.48-0.05
-0.19%
iShares iBonds Dec 2044 Term Trsy ETF